Sitryx Therapeutics
Houman joined SV in 2016 as a Venture Partner, was promoted to Partner in 2017 and became a Managing Partner in 2018.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Sitryx Therapeutics
Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation.